Ocular Genetic Diagnostic Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: O648AD978227EN
Market Monitor Global

Abstracts

There are around 5,000 genetic disorders and syndromes that affect the mankind. Of this vast number, at least one third of them are related to eyes. With the recent advancements in molecular genetics and various sequencing methods, a wide array of various hereditary eye diseases have been discovered.

This report contains market size and forecasts of Ocular Genetic Diagnostic in Global, including the following market information:

Global Ocular Genetic Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Ocular Genetic Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Next-generation Sequencing (NGS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ocular Genetic Diagnostic include Quest Diagnostics, Columbia ophthalmology, Centogene, DBGen, Medgenome, Sankara Nethralaya, Fulgent Genetics, GeneDx and Devyser and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ocular Genetic Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ocular Genetic Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Ocular Genetic Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Next-generation Sequencing (NGS)
• Multiplex Ligation-Dependent Probe Amplification (MLPA)
• Fragment Analysis PCR for Repeat Expansion Analysis

Global Ocular Genetic Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Ocular Genetic Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostic Laboratories
• Academic and Research Centers
• Others

Global Ocular Genetic Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Ocular Genetic Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ocular Genetic Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Ocular Genetic Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Quest Diagnostics
• Columbia ophthalmology
• Centogene
• DBGen
• Medgenome
• Sankara Nethralaya
• Fulgent Genetics
• GeneDx
• Devyser
• Invitae Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ocular Genetic Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ocular Genetic Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OCULAR GENETIC DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Ocular Genetic Diagnostic Market Size: 2021 VS 2028
2.2 Global Ocular Genetic Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ocular Genetic Diagnostic Players in Global Market
3.2 Top Global Ocular Genetic Diagnostic Companies Ranked by Revenue
3.3 Global Ocular Genetic Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Ocular Genetic Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ocular Genetic Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ocular Genetic Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Ocular Genetic Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ocular Genetic Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Ocular Genetic Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Next-generation Sequencing (NGS)
  4.1.3 Multiplex Ligation-Dependent Probe Amplification (MLPA)
  4.1.4 Fragment Analysis PCR for Repeat Expansion Analysis
4.2 By Type - Global Ocular Genetic Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Ocular Genetic Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Ocular Genetic Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ocular Genetic Diagnostic Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostic Laboratories
  5.1.4 Academic and Research Centers
  5.1.5 Others
5.2 By Application - Global Ocular Genetic Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Ocular Genetic Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Ocular Genetic Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ocular Genetic Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Ocular Genetic Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Ocular Genetic Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Ocular Genetic Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Ocular Genetic Diagnostic Revenue, 2017-2028
  6.3.2 US Ocular Genetic Diagnostic Market Size, 2017-2028
  6.3.3 Canada Ocular Genetic Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Ocular Genetic Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Ocular Genetic Diagnostic Revenue, 2017-2028
  6.4.2 Germany Ocular Genetic Diagnostic Market Size, 2017-2028
  6.4.3 France Ocular Genetic Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Ocular Genetic Diagnostic Market Size, 2017-2028
  6.4.5 Italy Ocular Genetic Diagnostic Market Size, 2017-2028
  6.4.6 Russia Ocular Genetic Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Ocular Genetic Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Ocular Genetic Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Ocular Genetic Diagnostic Revenue, 2017-2028
  6.5.2 China Ocular Genetic Diagnostic Market Size, 2017-2028
  6.5.3 Japan Ocular Genetic Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Ocular Genetic Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Ocular Genetic Diagnostic Market Size, 2017-2028
  6.5.6 India Ocular Genetic Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Ocular Genetic Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Ocular Genetic Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Ocular Genetic Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ocular Genetic Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Ocular Genetic Diagnostic Market Size, 2017-2028
  6.7.3 Israel Ocular Genetic Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Ocular Genetic Diagnostic Market Size, 2017-2028
  6.7.5 UAE Ocular Genetic Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Quest Diagnostics
  7.1.1 Quest Diagnostics Corporate Summary
  7.1.2 Quest Diagnostics Business Overview
  7.1.3 Quest Diagnostics Ocular Genetic Diagnostic Major Product Offerings
  7.1.4 Quest Diagnostics Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 Quest Diagnostics Key News
7.2 Columbia ophthalmology
  7.2.1 Columbia ophthalmology Corporate Summary
  7.2.2 Columbia ophthalmology Business Overview
  7.2.3 Columbia ophthalmology Ocular Genetic Diagnostic Major Product Offerings
  7.2.4 Columbia ophthalmology Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 Columbia ophthalmology Key News
7.3 Centogene
  7.3.1 Centogene Corporate Summary
  7.3.2 Centogene Business Overview
  7.3.3 Centogene Ocular Genetic Diagnostic Major Product Offerings
  7.3.4 Centogene Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Centogene Key News
7.4 DBGen
  7.4.1 DBGen Corporate Summary
  7.4.2 DBGen Business Overview
  7.4.3 DBGen Ocular Genetic Diagnostic Major Product Offerings
  7.4.4 DBGen Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 DBGen Key News
7.5 Medgenome
  7.5.1 Medgenome Corporate Summary
  7.5.2 Medgenome Business Overview
  7.5.3 Medgenome Ocular Genetic Diagnostic Major Product Offerings
  7.5.4 Medgenome Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 Medgenome Key News
7.6 Sankara Nethralaya
  7.6.1 Sankara Nethralaya Corporate Summary
  7.6.2 Sankara Nethralaya Business Overview
  7.6.3 Sankara Nethralaya Ocular Genetic Diagnostic Major Product Offerings
  7.6.4 Sankara Nethralaya Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 Sankara Nethralaya Key News
7.7 Fulgent Genetics
  7.7.1 Fulgent Genetics Corporate Summary
  7.7.2 Fulgent Genetics Business Overview
  7.7.3 Fulgent Genetics Ocular Genetic Diagnostic Major Product Offerings
  7.7.4 Fulgent Genetics Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Fulgent Genetics Key News
7.8 GeneDx
  7.8.1 GeneDx Corporate Summary
  7.8.2 GeneDx Business Overview
  7.8.3 GeneDx Ocular Genetic Diagnostic Major Product Offerings
  7.8.4 GeneDx Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 GeneDx Key News
7.9 Devyser
  7.9.1 Devyser Corporate Summary
  7.9.2 Devyser Business Overview
  7.9.3 Devyser Ocular Genetic Diagnostic Major Product Offerings
  7.9.4 Devyser Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 Devyser Key News
7.10 Invitae Corporation
  7.10.1 Invitae Corporation Corporate Summary
  7.10.2 Invitae Corporation Business Overview
  7.10.3 Invitae Corporation Ocular Genetic Diagnostic Major Product Offerings
  7.10.4 Invitae Corporation Ocular Genetic Diagnostic Revenue in Global Market (2017-2022)
  7.10.5 Invitae Corporation Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ocular Genetic Diagnostic Market Opportunities & Trends in Global Market
Table 2. Ocular Genetic Diagnostic Market Drivers in Global Market
Table 3. Ocular Genetic Diagnostic Market Restraints in Global Market
Table 4. Key Players of Ocular Genetic Diagnostic in Global Market
Table 5. Top Ocular Genetic Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ocular Genetic Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ocular Genetic Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ocular Genetic Diagnostic Product Type
Table 9. List of Global Tier 1 Ocular Genetic Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ocular Genetic Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ocular Genetic Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ocular Genetic Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ocular Genetic Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ocular Genetic Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ocular Genetic Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ocular Genetic Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ocular Genetic Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ocular Genetic Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ocular Genetic Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ocular Genetic Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Quest Diagnostics Corporate Summary
Table 31. Quest Diagnostics Ocular Genetic Diagnostic Product Offerings
Table 32. Quest Diagnostics Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Columbia ophthalmology Corporate Summary
Table 34. Columbia ophthalmology Ocular Genetic Diagnostic Product Offerings
Table 35. Columbia ophthalmology Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Centogene Corporate Summary
Table 37. Centogene Ocular Genetic Diagnostic Product Offerings
Table 38. Centogene Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. DBGen Corporate Summary
Table 40. DBGen Ocular Genetic Diagnostic Product Offerings
Table 41. DBGen Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Medgenome Corporate Summary
Table 43. Medgenome Ocular Genetic Diagnostic Product Offerings
Table 44. Medgenome Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Sankara Nethralaya Corporate Summary
Table 46. Sankara Nethralaya Ocular Genetic Diagnostic Product Offerings
Table 47. Sankara Nethralaya Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Fulgent Genetics Corporate Summary
Table 49. Fulgent Genetics Ocular Genetic Diagnostic Product Offerings
Table 50. Fulgent Genetics Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. GeneDx Corporate Summary
Table 52. GeneDx Ocular Genetic Diagnostic Product Offerings
Table 53. GeneDx Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Devyser Corporate Summary
Table 55. Devyser Ocular Genetic Diagnostic Product Offerings
Table 56. Devyser Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Invitae Corporation Corporate Summary
Table 58. Invitae Corporation Ocular Genetic Diagnostic Product Offerings
Table 59. Invitae Corporation Ocular Genetic Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Ocular Genetic Diagnostic Segment by Type in 2021
Figure 2. Ocular Genetic Diagnostic Segment by Application in 2021
Figure 3. Global Ocular Genetic Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ocular Genetic Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ocular Genetic Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ocular Genetic Diagnostic Revenue in 2021
Figure 8. By Type - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ocular Genetic Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ocular Genetic Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Quest Diagnostics Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Columbia ophthalmology Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Centogene Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. DBGen Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Medgenome Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sankara Nethralaya Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Fulgent Genetics Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GeneDx Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Devyser Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Invitae Corporation Ocular Genetic Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)